The US Food and Drug Administration (FDA) on Wednesday released final guidance for sponsors on when a standard release test and criteria may be used in lieu of extensive method development and ...
Thousands of blood pressure pills are being recalled nationwide. Here’s what drug is affected, why the FDA pulled it and what patients should know now ...
The U.S. Food and Drug Administration has announced a nationwide recall of thousands of bottles of a commonly prescribed blood pressure medication after testing revealed a potential problem that could ...
More than 11,000 bottles of a popular blood pressure medication are being recalled after lab testing showed that the drug may be ineffective. According to the U.S. Food and Drug Administration, the ...
System addresses the pharmaceutical industry’s need for compliant, semi-automated testing of nanoparticle drug formulations. SANTA CLARA, Calif.--(BUSINESS WIRE)-- Agilent Technologies Inc. (NYSE: A) ...
Teva issued a voluntary recall for two lots of its hypertension drug Matzim LA (diltiazem hydrochloride) after testing found the extended-release tablets failed to dissolve correctly. The recalled ...
Inventia Healthcare Limited, based in Mumbai, India, issued a voluntary recall on June 5, 2026 for certain batches of the Chlorthalidone tablets it manufactured. The FDA classified it as a Class II ...
When you take a time-release drug, you count on it doing what the package says: release the drug slowly into your bloodstream to provide benefits over the specified period of time. When the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results